Key developments span drug approvals for rare diseases, probiotics' brain effects, infectious disease resurgence, and emerging aesthetic market opportunities alongside legal developments in abortion access.
Key Points
Mirum Pharmaceuticals' experimental drug volixibat successfully met its primary endpoint in mid-stage trials by significantly reducing severe itching (pruritus) in patients with a rare liver disease, advancing toward potential regulatory approval.
A randomized controlled trial demonstrates that four weeks of probiotic supplementation produces positive microstructural and functional changes in multiple brain regions of irritable bowel syndrome (IBS) patients, linking gut health to neurological improvements.
South Carolina confirmed a second measles case in Saluda County linked to the initial case from April, highlighting the resurging public health threat of the highly contagious disease in specific communities.
Aesthetic and cosmetic firms are positioning themselves to capitalize on a growing patient population experiencing loose skin and facial volume loss as side effects of GLP-1 weight-loss medications, creating a new market segment.
The U.S. Supreme Court temporarily reinstated federal regulations allowing mifepristone (abortion pill) to be prescribed via telemedicine and dispensed by mail, temporarily halting restrictions on medication abortion access.
A large international study identifies changes in gut microbiome composition as a potential early biomarker for identifying Parkinson's disease risk, including in genetically predisposed individuals without current symptoms.
Clinical guidelines clarify when neurosurgical intervention is necessary for traumatic brain injury, specifically for patients with declining Glasgow Coma Scale scores below 8, new neurological deficits, or imaging showing large epidural or subdural hematomas.
The modified amino acid levacetylleucine demonstrated clinically meaningful therapeutic benefits in a Phase 3 trial for ataxia-telangiectasia, a rare genetic neurological disorder affecting children and adults.